Breadcrumb

Home
Topics
COVID-19

COVID-19 and drugs

Publications
News
Events
Document library
Media library
External links

Overview

COVID-19 is the name of a disease caused by a coronavirus and was first reported in December 2019 in Wuhan, Hubei Province, China. The World Health Organization declared COVID-19 a global pandemic in March 2020 and all EU countries and the UK are affected. How is the COVID-19 pandemic affecting people who use drugs and those who provide services to them? Has there been an impact on the drug market? This page brings together a range of resources on COVID-19 and drugs, from the EMCDDA, partner organisations and others.

COVID-19 and drugs: woman wearing surgical mask overlaid with images of a virus

Publications

Publications by the EMCDDA on this topic

Filter

Keywords

Cannabis – the current situation in Europe (European Drug Report 2023)

2023
European Drug Report 2022: Trends and Developments

2022
Drug-related infectious diseases (DRID): update from the expert network, October 2021

2022
European Web Survey on Drugs 2021: top-level findings, Western Balkans

2022
Spotlight on… Health and social responses to drug problems during the COVID-19 pandemic

2021
EMCDDA trendspotter briefing – Illicit drug markets and supply in the Western Balkans: Impact of COVID-19

2021
European Drug Report 2021: Trends and Developments

2021
Exploring drug supply, associated violence and exploitation of vulnerable groups in Denmark

2021
Impact of COVID-19 on drug markets, use, harms and drug services in the community and prisons

2021
EMCDDA trendspotter briefing: Impact of COVID-19 on drug use and drug services in Western Balkans

2021
Impact of COVID-19 on drug markets, drug use, drug-related harms and responses in south European Neighbourhood Policy countries

2020
New psychoactive substances: global markets, glocal threats and the COVID-19 pandemic — an update from the EU Early Warning System

2020
Meeting report – Expert meeting on drug-related infectious diseases (DRID) 2020

2020
Reitox national focal points’ activities during the COVID-19 pandemic

2020
EMCDDA trendspotter briefing: Impact of COVID-19 on drug markets, drug use, drug-related harms and responses in east European Neighbourhood Policy countries

2020

Pagination

Current page 1
Page 2
Next page
Last page

News

Read our most recent news on this topic

EMCDDA: committed to protecting public health and supporting vulnerable populations (May 2023 )
Drug supply and use bounce back after COVID-19 disruption (June 2022 )
EMCDDA releases third trendspotter study on COVID-19 and drugs (April 2021 )
EMCDDA releases study findings on the impact of COVID-19 on drug markets, use and services in the southern ENP region (December 2020 )
COVID-19 disruption and a strong drug market bring new threats to health and security in Europe (September 2020 )
EMCDDA welcomes external partners to virtual event on lessons learned from the impact of COVID-19 on the drug situation in Europe (June 2020 )
Speech by Alexis Goosdeel: Closing remarks on the impact of the COVID-19 pandemic on the world drug situation — the European perspective (June 2020 )
EMCDDA and Europol join EU institutions in dialogue on the impact of COVID-19 on the world drug situation (June 2020 )
COVID-19: New EMCDDA study highlights decline in stimulant drug use but some rises in the use of cannabis, alcohol and prescription medicines to combat anxiety and depression (June 2020 )
Impact of COVID-19 on the drug situation in Europe — EMCDDA Director presents findings to European Parliament (June 2020 )
New report provides window onto EU drug market changes during COVID-19 (May 2020 )
COVID-19: New EMCDDA study highlights drop in availability of drug services in Europe but increase in innovation (May 2020 )
Increase in darknet market activity for cannabis as users stock up for lockdown (May 2020 )
EMCDDA launches COVID-19 special round of European Web Survey on Drugs to assess impact of pandemic (April 2020 )
EMCDDA publishes update on the implications of COVID-19 for people who use drugs and for drug service providers (March 2020 )

Pagination

Current page 1
Page 2
Next page
Last page

Events

Related events, meetings, conferences and more from our events calendar

EMCDDA webinar: How wastewater monitoring can boost preparedness for new health threats (16 Nov 2022, Online)
2021 NIDA International Forum (21 Jun 2021 to 24 Jun 2021, Online)
Expert Group Briefing on Harm Reduction (27 May 2021, Online)
41st EAPCCT Congress (24 May 2021 to 28 May 2021, Online)
Webinar on pathological addictions (Italian) (14 May 2021, Online)
The impact of the COVID-19 pandemic on drug indicators at European level (28 Apr 2021, Online)
Coffee talks: The impact of the COVID-19 pandemic on drug trafficking and drug use in Europe (27 Apr 2021, Online)
CND Side event: ‘COVID-19 pandemic and its influence on the world drug problem: New challenges and prospects’ (12 Apr 2021)
Prevalence and patterns of drug use expert meeting 2021 (30 Mar 2021 to 31 Mar 2021, Online)
EMCDDA webinar: COVID-19 and drugs in the European neighbourhood: lessons learned from Ukraine and Georgia (25 Mar 2021, Online)
Webinar on EU Drugs Agenda 2021 – 2025 (24 Mar 2021, Online)
Launch of report EMCDDA trendspotter briefing: Impact of COVID-19 on drug use and drug services in Western Balkans (09 Mar 2021)
EMCDDA webinar: COVID-19 induced recession and drug-related problems (16 Dec 2020, Online)
Meeting of the Training Contact Group of the JHA Agencies’ Network (27 Oct 2020, Online)
8th Annual meeting of the EMCDDA reference group on drug supply indicators (26 Oct 2020 to 27 Oct 2020, Online)

Pagination

Current page 1
Page 2
Page 3
Next page
Last page

Document library

Documents on this topic in our Document Library

Use of Psychoactive Substances during COVID-19 in Republic of North Macedonia (2022 )
The impact of the COVID-19 lockdown on drug service provision in European prisons (2021 )
Changes in drug use in European cities during early COVID-19 lockdowns (2021 )
Drug-related violence: Will COVID-19 drive better data for safer and more secure EU? (2021 )
Monitoring an online illicit drug market during COVID 19 in Georgia (2021 )
A global study of the escalation of substance use and its association with mental health symptoms during the early wave of the COVID-19 Pandemic (2021 )
COVID-19 and drugs in the European neighbourhood partnership countries (2021 )
Webinar presentation: Impact of the COVID-19 epidemic on drug markets, substance use patterns, and delivery of harm reduction and treatment services in Georgia and Ukraine (2021 )
Mini-European web survey on drugs — Impact of COVID-19 on drug use, acquisition behaviour and the drug market in Luxembourg (2021 )
Impact of the COVID-19 epidemic on drug markets, substance use patterns, and delivery of harm reduction and treatment services in Ukraine (2021 )
The double effect of COVID-19 confinement measures and economic recession on high-risk drug users and drug services (2021 )
The double effect of COVID-19 confinement measures and economic recession on high-risk drug users and drug services (2021 )
Impact of the COVID-19 epidemic on drug markets and behavior of people who use drugs in Georgia (2021 )
Impact of COVID-19 on consumer practices and the use of specialised offers by high-risk drug users in the Grand Duchy of Luxembourg: findings from a quantitative study (2021 )
European Commission - Coronavirus vaccines strategy (2020 )